English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52696964    Online Users :  988
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"kuo y h"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 11-20 of 311  (32 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-03-08T03:44:06Z Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2022-02-23T02:12:21Z Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus Kuo Y.-H.; Kee K.-M.; Hung C.-H.; Lu S.-N.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-23T02:12:18Z Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767) Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-23T02:12:18Z Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-22T05:34:11Z Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus Kuo Y.-H.; Kee K.-M.; Hung C.-H.; Lu S.-N.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-22T05:34:08Z Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-22T05:34:07Z Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767) Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
國立成功大學 2022 A synthesized retail brand personality framework: a�cross-cultural study of Taiwan and the United States Kuo, Y.-H.;Wu, P.-C.;Ahn, S.Y.
國立成功大學 2022 Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities Wu, N.-C.;Feng, Y.-H.;Kuo, Y.H.;Chen, W.-Y.;Wu, H.-C.;Huang, C.-T.;Wang, Wang W.-C.;Kang, N.-W.;Shih, J.-Y.;Chen, Z.-C.;Chang, W.-T.
國立成功大學 2022 The retail brand personality—Behavioral outcomes framework: Applications to identity and social identity theories Kuo, Y.-H.

Showing items 11-20 of 311  (32 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page